Dr. Rob Burgess shares how Sino Biological empowers global biomedical research through precision, quality, and ...

Following a significant debt restructuring last year, Sino-Ocean Holding ADR has released its preliminary sales figures for January 2026. The data offers an initial glimpse into the company's ...

In September 2009, GMI Ratings’ AGR (accounting governance risk) rating for Sino-Forest Corporation, which filed for bankruptcy protection on March 30th 2012, moved into the Aggressive range, ...

Hong Kong-listed Sino Biopharmaceutical will acquire China-based oncology specialist LaNova Medicines in a deal that will not exceed $951m, representing one of the largest transactions within the Asia ...

Sino Biopharmaceutical Ltd. operates as an investment holding company, which engages in the manufacturing and selling of pharmaceutical products. The company operates through the following business ...

When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right business to buy shares in, you can make more than you can lose. For example, the ...

The fund aimed to raise $200 million and primarily targeted high net worth individuals. This approach marked a departure for Sino, as it was the first time the firm sought outside capital through a ...

Sino Global Capital, one of Asia’s biggest and most well-known crypto investors and led by Matthew Graham, tweeted a statement this week that its “direct exposure to FTX exchange was confined to ...